Gj. Cianciolo et al., Covalent complexes of antigen and alpha(2)-macroglobulin: evidence for dramatically-increased immunogenicity, VACCINE, 20(3-4), 2001, pp. 554-562
A safe. effective, more potent adjuvant than currently available would be b
eneficial in developing new therapeutics and diagnostic reagents, We report
here a technique for the rapid, efficient incorporation of non-proteolytic
antigens into alpha (2)-macroglobulin (alpha M-2; tradename. SynerVax (TM)
), allowing us to covalently couple much larger subunit antigens to alpha M
-2 than previously possible. Our goal was to determine if incorporation of
HB, the monomeric form of Hepatitis B virus (HBV) surface antigen (HBsAg),
into alpha M-2 would result in increased immune reactivity. Earlier attempt
s to immunize animals using HB did not generate significant levels of antib
odies. Using HB complexes prepared with alpha M-2 we now report dramatic al
ly-increased immunogenicity of HB in BALB/c mice, Combining these soluble c
omplexes with a depot-generating agent (alum), titers > 1:1,000,000 are obt
ained with a single injection. This novel adjuvant technology should provid
e a valuable tool for the development of either prophylactic and therapeuti
c vaccines, or monoclonal antibodies against hitherto poorly-immunogenic su
bunit antigens. (C) 2001 Published by Elsevier Science Ltd.